A paper by Ken Ishii’s group (Division of Adjuvant Innovation) was published in Journal of Immunology.
2023年12月8日
A paper by Ken Ishii’s group (Division of Adjuvant Innovation) was published in Journal of Immunology.
TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model.
J Immunol. 2024 Feb 1;212(3):455-465. doi: 10.4049/jimmunol.2300038.